Relevance of 99mTc-HYNIC-tir-octreotide scintigraphy in a patient affected by sarcoidosis with lung and joints involvement and secondary Sjogren's syndrome treated with infliximab: case report.
We report the case of a 59 years old woman affected by lung and joint sarcoidosis, secondary Sjogren's syndrome refractory to common disease-modifying antirheumatic drugs (DMARDs) that regressed with infliximab and methotrexate. 99mTc-HYNIC-TOC scintigraphy was useful in diagnosis, choice of treatment and follow-up.
Migliore
A
A
UOS of Rheumatology, Fatebenefratelli, S. Pietro Hospital, Rome, Italy. albertomigliore@terra.es
Signore
A
A
Capuano
A
A
Bizzi
E
E
Massafra
U
U
Vacca
E
E
Todino
V
V
Chianelli
M
M
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000627:therapeutic use; D005260:Female; D006801:Humans; D000069285:Infliximab; D008727:Methotrexate / Q000627:therapeutic use; D008875:Middle Aged; D015609:Organotechnetium Compounds; D011877:Radionuclide Imaging / Q000379:methods*; D019275:Radiopharmaceuticals; D012507:Sarcoidosis / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D012859:Sjogren's Syndrome / Q000000981:diagnostic imaging* / Q000188:drug therapy* / Q000209:etiology
D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D015609:Organotechnetium Compounds; D019275:Radiopharmaceuticals; C487389:technetium 99m EDDA-HYNIC-Tyr(3)-octreotide; D000069285:Infliximab; D008727:Methotrexate